10.51 USD
↗ 0.29 (2.84%)AT CLOSE (11:59 AM EDT)
Atara Biotherapeutics, Inc (ATRA) trades at $10.51 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (25.4%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place ATRA at a fair price relative to peers.
Technical & fundamental data as of Jun 26, 2026.